Ame. Nouri et al., EPIDERMAL GROWTH FACTOR-INDUCED PROTECTION OF TUMOR-CELL SUSCEPTIBILITY TO CYTOLYSIS, European journal of cancer, 31A(6), 1995, pp. 963-969
Using radiobinding, transfection and colorimetric assays, the biologic
al significance of epidermal growth factor (EGF) and its receptor on e
stablished human tumour cell lines was investigated. The intensity of
class I major histocompatibility antigen (MHC) and EGF receptor (EGFR)
expression on 20 tumour cell lines was investigated and showed no dir
ect correlation (coefficient of correlation r = 0.43 and P = 0.06). Fu
rthermore, transfection of the beta 2-microglobulin gene into a class
I negative bladder tumour cell line, resulting in the re-expression of
fully assembled cell surface class I antigens, did not result in alte
ration of EGFR expression. However, there was an inverse correlation b
etween the intensity of EGFR expression and the stimulatory response o
f cells to exogenously added EGF. The per cent inhibitions of cell pro
liferation by EGF at 100 ng/ml for A431 (highest EGFR expressor) and S
caber (lowest EGFR expressor) were 37 and -7%, respectively. The resul
ts also showed that cell lines isolated from testis tumours positive f
or epithelial markers (using pan keratin antibody LP34 as an epithelia
l marker), expressed significantly lower EGFR levels than cell lines f
rom bladder tumours. The expression of EGFR receptor was not modulated
by interferons (IFN-alpha and -gamma and only a minor effect with IFN
-beta) or active supernatant containing a mixture of cytokines. Whilst
the pretreatment of tumour cells with IFNs resulted in a significant
increase in the susceptibility of tumour cells to interleukin-2-activa
ted peripheral blood mononuclear cells, EGF treatment resulted in thei
r protection. Thus, the per cent killing at an effector:target ratio o
f 20:1 for untreated cells and EGF (100 ng/ml), IFN-alpha (1000 U/ml),
-beta (2000 U/ml) and -gamma (100 U/ml) were 53%, 33% (P = 0.004), 64
% (P = 0.004), 69% (P = 0.001) and 66% (P = 0.001), respectively. Thes
e results indicate the complex interactions between EGF and EGFR and t
heir relevance in modifying tumour cell behaviour. The hypothesis that
the resistance to cytolysis of tumour cells induced by EGF stimulatio
n may be a factor in the accelerated tumour growth seen in patients af
ter traumatic tissue damage is discussed.